Sean Lee CFA

Stock Analyst at H.C. Wainwright

(2.60)
# 2,977
Out of 4,698 analysts
266
Total ratings
34%
Success rate
1.5%
Average return
Main Sectors:

Stocks Rated by Sean Lee CFA

Dogwood Therapeutics
Sep 2, 2026
Maintained: Buy
Price Target: $12
Current: $2.29
Upside: +424.02%
Akari Therapeutics,
Aug 18, 2026
Reiterated: Buy
Price Target: $27
Current: $11.47
Upside: +135.40%
Corvus Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $27
Current: $14.39
Upside: +87.63%
Cytosorbents
Aug 7, 2026
Maintained: Hold
Price Target: $0.75
Current: $0.3501
Upside: +114.22%
Senseonics Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $14
Current: $9.63
Upside: +45.38%
Myomo
Aug 7, 2026
Maintained: Buy
Price Target: $5
Current: $1.44
Upside: +247.22%
Alphatec Holdings
Aug 5, 2026
Maintained: Buy
Price Target: $24
Current: $9.45
Upside: +153.97%
Kazia Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $12.31
Upside: +46.22%
Novavax
Apr 21, 2026
Reiterated: Buy
Price Target: $16
Current: $10.22
Upside: +56.56%
Cerenome
Mar 16, 2026
Reiterated: Buy
Price Target: $25
Current: $2.76
Upside: +807.44%
Maintained: Buy
Price Target: $4
Current: $0.153
Upside: +2,514.38%
Reiterated: Buy
Price Target: $14
Current: $8.20
Upside: +70.73%
Maintained: Buy
Price Target: €14.00
Current: €2.99
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $2.08
Upside: n/a
Maintained: Buy
Price Target: $40
Current: $117.56
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a